Renji Medicine Co., Ltd. is a joint stock limited company (unlisted, natural person invested or controlled) incorporated on 2014-06-18, with its registered office located at No. 5 door of Building No. 1, Haeming East Road, Baicheng City.
Renji Pharmaceutical Co., Ltd.'s unified social credit code / registration number is 912208003079080996, the enterprise's legal person Sui Liqin, the enterprise is currently in the state of cancellation.
Renji Pharmaceutical Co., Ltd. business scope is: medical equipment and reagents distribution; medical equipment repair, electronic component repair; food and health care pharmaceutical R & D and sales; national key pharmaceutical R & D contracting; pharmaceutical R & D outsourcing contracting; the use of enterprise-owned funds on medical and pharmaceutical industry investment; pharmaceutical information technology development, consulting; animal husbandry R & D, animal husbandry engineering equipment sales; Precision instruments, laboratory instruments and meters, electronic communication equipment; enterprise marketing planning, enterprise information technology consulting; e-commerce, e-commerce information consulting sales; computer software, hardware, computer network equipment, technology development, technical consulting and sales, computer system maintenance, computer system integration, website design, network engineering construction; intelligent lighting, weak power engineering, intelligent system engineering, Building monitoring construction and weak power equipment, monitoring equipment sales; hardware and electrical materials, labor insurance supplies, cultural goods, household appliances sales; water treatment equipment sales and maintenance maintenance; disinfection products sales. (Items subject to approval by law, can only carry out business activities after approval by the relevant departments). Within this province, the current registered capital of the enterprise is excellent.
View more information and information about Renji Pharmaceutical Co. through Baidu Enterprise Credit.